Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
01/05/2011 | EP2270185A2 Defensin polynucleotides and methods of use |
01/05/2011 | EP2270184A2 Defensin polynucleotides and methods of use |
01/05/2011 | EP2270177A1 Streptococcus pneumoniae proteins and nucleic acids |
01/05/2011 | EP2270176A1 Streptococcus pneumoniae proteins and nucleic acids |
01/05/2011 | EP2270175A1 Streptococcus pneumoniae proteins and nucleic acids |
01/05/2011 | EP2270174A1 Combination neisserial compositions |
01/05/2011 | EP2270173A1 Combination neisserial compositions |
01/05/2011 | EP2270172A1 Combination neisserial compositions |
01/05/2011 | EP2270171A2 Haemophilus influenzae antigens and corresponding DNA fragments |
01/05/2011 | EP2270170A1 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
01/05/2011 | EP2270169A2 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
01/05/2011 | EP2270168A1 Mutant gene capable of controlling the oil-and-fat content in seed, and method for controlling the oil-and-fat content in seed |
01/05/2011 | EP2270167A2 Polynucleotides and polypeptides in plants |
01/05/2011 | EP2270166A2 Polynucleotides and polypeptides in plants |
01/05/2011 | EP2270165A2 Defensin polynucleotides and methods of use |
01/05/2011 | EP2270164A2 Recombinant protein variants |
01/05/2011 | EP2270163A1 Muteins of fibroblast growth factor 21 |
01/05/2011 | EP2270158A2 Bitter taste receptors |
01/05/2011 | EP2270157A2 Bitter taste receptors |
01/05/2011 | EP2270156A2 Bitter taste receptors |
01/05/2011 | EP2270155A2 Bitter taste receptors |
01/05/2011 | EP2270154A2 Bitter taste receptors |
01/05/2011 | EP2270153A2 Bitter taste receptors |
01/05/2011 | EP2270152A1 Expression system using mammalian beta-actin promoter |
01/05/2011 | EP2270145A1 Novel protein capable of binding to hyaluronic acid, and method for measurement of hyaluronic acid using the same |
01/05/2011 | EP2270141A1 Partial peptide of lacritin |
01/05/2011 | EP2270055A2 Cell-permeable endostatin recombinant protein, a polynucleotide encoding the same, and an anti-cancer preparation containing the same as an active component |
01/05/2011 | EP2270049A2 Recombinant anti-interleukin-9-antibody |
01/05/2011 | EP2270048A2 Anti-NGF antibodies and methods using same |
01/05/2011 | EP2270047A2 Anti-C5 antibodies and their therapeutic uses |
01/05/2011 | EP2270046A2 Methods and compositions for the treatment of hemolysis-associated diseases |
01/05/2011 | EP2270043A1 Extracellular allosteric inhibitor binding domain from a tyrosine kinase receptor |
01/05/2011 | EP2270042A2 KDR peptides and vaccines comprising the same |
01/05/2011 | EP2270041A2 KDR peptides and vaccines comprising the same |
01/05/2011 | EP2270040A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS) |
01/05/2011 | EP2270039A1 Peptides having activities of insulin like growth factor-1 and their uses |
01/05/2011 | EP2270038A2 GAG binding proteins |
01/05/2011 | EP2270037A2 Hasylated Factor IX |
01/05/2011 | EP2270036A2 Hasylated polypeptides |
01/05/2011 | EP2270035A2 Peptides enhancing CEH activity, pharmaceutical compositions comprising these peptides and their use in the treatment of atherosclerosis |
01/05/2011 | EP2270034A2 Agents and methods for diagnosing stress |
01/05/2011 | EP2270033A1 Microtubes comprising components of the external membrane of E. coli cells and recombinant S-layer proteins, method for producing same and application |
01/05/2011 | EP2270032A2 Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeenis |
01/05/2011 | EP2270031A2 Heterologous expression of neisserial proteins |
01/05/2011 | EP2270030A2 Heterologous expression of Neisserial proteins |
01/05/2011 | EP2270029A1 E.coli secretion system on the basis of S-layer proteins |
01/05/2011 | EP2270028A1 Biomolecule-immobilized carrier and method for immobilizing biomolecule on carrier |
01/05/2011 | EP2269643A2 Hcv vaccine compositions |
01/05/2011 | EP2269642A2 Hcv vaccine compositions |
01/05/2011 | EP2269641A2 Hcv vaccine compositions |
01/05/2011 | EP2269640A2 Hcv vaccine compositions |
01/05/2011 | EP2269634A2 Antigenic polypeptides |
01/05/2011 | EP2269629A2 Compositions and methods for producing antigen-presenting cells |
01/05/2011 | EP2269471A1 Method for production of defatted soymilk peptide |
01/05/2011 | EP2269071A1 Methods and agents for the diagnosis and treatment of hepatocellular carcinoma |
01/05/2011 | EP2268837A1 Diagnosis of hereditary spastic paraplegias (hsp) by identification of a mutation in the zfyve26 gene or protein |
01/05/2011 | EP2268833A1 Freeze-free method for storage of polypeptides |
01/05/2011 | EP2268814A1 Compositions and methods related to silicon transport |
01/05/2011 | EP2268800A1 A newly identified human rhinovirus of hrv-c and methods and kits for detecting hrv-cs |
01/05/2011 | EP2268673A2 Polypeptide-polymer conjugates and methods of use thereof |
01/05/2011 | EP2268667A2 Somatostatin receptor 2 antagonists |
01/05/2011 | EP2268666A1 Recombinant fsh including alpha 2,3- and alpha 2,6-sialylation |
01/05/2011 | EP2268665A1 Peptide composition for cancer treatment by inhibiting trpv6 calcium channel activity |
01/05/2011 | EP2268664A2 Doc1 compositions and methods for treating cancer |
01/05/2011 | EP2268663A1 Recombinant protein enriched in a heparin binding site and/or a heparan sulfate binding site |
01/05/2011 | EP2268662A2 Hypoallergenic hybrid proteins of major group 1 and 2 mite allergens for use in the treatment of allergies |
01/05/2011 | EP2268661A2 Method of cloning stable stress tolerant superoxide dismutase using degenerate primers |
01/05/2011 | EP2268660A1 Anti-lps factor from parietaria judaica and methods of use thereof |
01/05/2011 | EP2268659A2 Mutant forms of chlamydia htra |
01/05/2011 | EP2268607A2 Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid |
01/05/2011 | EP2268298A1 Novel gp96 derived peptides |
01/05/2011 | EP2268297A1 Modified toxins |
01/05/2011 | EP2268289A1 Anti-infective agents and uses thereof |
01/05/2011 | EP2268135A2 Screening for non-genotoxic carcinogens |
01/05/2011 | EP2016950B1 Pharmaceutical composition comprising an exendin-4 peptide |
01/05/2011 | EP1922334B1 Tumor-associated peptides binding to human leukocyte antigen (hla) class i or ii molecules and related anti-cancer vaccine |
01/05/2011 | EP1727830B1 Mussel bioadhesive |
01/05/2011 | EP1603941B1 Inhibitors of extracellular hsp90 |
01/05/2011 | EP1549336B1 Prevention and/or treatment of ulcerative colitis using pyy or pyy[3-36] |
01/05/2011 | EP1546182B1 Compositions and methods for the diagnosis and treatment of tumor |
01/05/2011 | EP1493034B1 Method for diagnosing inflammatory diseases and infections by the determination of lasp-1 immunoreactivity |
01/05/2011 | EP1453471B1 Expression vectors encoding epitopes of antigens and methods for their design |
01/05/2011 | EP1437043B1 Rat model with overexpression of regucalcin |
01/05/2011 | EP1401467B1 Alpha-fetoprotein peptides and uses thereof |
01/05/2011 | EP1334197B1 Yeast derived vaccine against ipnv |
01/05/2011 | EP1317484B2 Variants of the phleum pratense phl p 1 allergenic protein |
01/05/2011 | EP1307218B1 Treatment of obesity |
01/05/2011 | EP1301202B1 Genetically-engineered mhc molecules |
01/05/2011 | EP1294769B1 Antibodies that immunospecifically bind to blys |
01/05/2011 | EP0815129B1 Ingap protein involved in pancreatic islet neogenesis |
01/05/2011 | DE102009032646A1 E. coli-Sekretionssystem auf der Basis von S-Layer-Proteinen E. coli secretion system on the basis of S-layer proteins |
01/05/2011 | DE102009030321A1 Verfahren zur Abbildung von Tumorgewebe A method for imaging tumor tissue |
01/05/2011 | CN101939656A Method and device for measuring the temperature of a hot spot in an oil-containing electric apparatus |
01/05/2011 | CN101939445A Polynucleotides and methods for making plants resistant to fungal pathogens |
01/05/2011 | CN101939443A Modified leptin polypeptides and their uses |
01/05/2011 | CN101939436A Maize stress-responsive NAC transcription factors and promoter and methods of use |
01/05/2011 | CN101939423A System for capturing and modifying large pieces of genomic DNA and constructing organisms with synthetic chloroplasts |
01/05/2011 | CN101939332A Truncated variant of the mammalian target for rapamycin (mTOR) protein |
01/05/2011 | CN101939331A A plant regulatory region that directs transgene expression in the maternal and supporting tissue of maize ovules and pollinated kernels |
01/05/2011 | CN101939330A Novel rubella E1 envelope protein variants and their use in the detection of anti-rubella antibodies |